Successful Left Ventricular Assist Device Re-implantation with Omental Covering for MDRP Device Infection

Overview

Journal J Artif Organs

Specialty Biomedical Engineering

Date 2016 Jan 8

PMID 26740211

Citations 2

Authors

Hitoshi Inafuku

Yukio Kuniyoshi

Satoshi Yamashiro

Yuichi Totsuka

Minoru Ono

Affiliations

Soon will be listed here.

Abstract

We present a case of paracorporeal left ventricular assist device (p-LVAD)-related infection, caused by multi-drug resistant Pseudomonas aeruginosae (MDRP), and successfully treated by p-LVAD re-implantation with omental covering. A 59-year-old man underwent p-LVAD implantation and coronary artery bypass grafting after percutaneous cardiopulmonary support and intra-aortic balloon pumping for cardiogenic shock due to acute myocardial infarction. Then, he was registered for heart transplantation. He suffered from blood stream infection causative organism of Pseudomonas aeruginosa, 2 months after that operation. He underwent re-median sternotomy and open drainage, 15 months after the p-LVAD implantation. However, he suffered from septic shock due to MDRP. He underwent p-LVAD re-implantation under hypothermic circulatory arrest and iodine gauze packing, followed by omental covering of the all artificial materials in his body 10 days after that operation. Soon after that, the infection was well controlled and the intravenous antibiotics could be discontinued 2 months after that operation. He successfully underwent heart transplantation, 17 months after that procedure. We concluded that p-LVAD re-implantation with omental covering is seemed to be useful in the treatment of massive device infection. This procedure might be a novel treatment for severe VAD-related infection until heart transplantation.

Citing Articles

Journal of Artificial Organs 2016: the year in review : Journal of Artificial Organs Editorial Committee.

Sawa Y, Matsumiya G, Matsuda K, Tatsumi E, Abe T, Fukunaga K J Artif Organs. 2017; 20(1):1-7.

PMID: 28197736 DOI: 10.1007/s10047-017-0945-x.

Successful management of apical abscess after Nipro left ventricular assisted device explantation by removal of apical cuff and omentopexy.

Yoshitake S, Itoda Y, Nawata K, Iwase T, Hoshino Y, Kimura M J Artif Organs. 2016; 19(4):396-398.

PMID: 27507585 DOI: 10.1007/s10047-016-0924-7.

References

Yoshioka D, Sakaguchi T, Saito S, Miyagawa S, Nishi H, Yoshikawa Y . Initial experience of conversion of Toyobo paracorporeal left ventricular assist device to DuraHeart left ventricular assist device. Circ J. 2011; 76(2):372-6. DOI: 10.1253/circj.cj-11-0833. View

Frazier O, Rose E, Oz M, Dembitsky W, McCarthy P, Radovancevic B . Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001; 122(6):1186-95. DOI: 10.1067/mtc.2001.118274. View

Sasaoka T, Kato T, Komamura K, Takahashi A, Nakajima I, Oda N . Improved long-term performance of pulsatile extracorporeal left ventricular assist device. J Cardiol. 2010; 56(2):220-8. DOI: 10.1016/j.jjcc.2010.05.010. View

Suwa H, Seguchi O, Fujita T, Murata Y, Hieda M, Watanabe T . Paracorporeal ventricular assist device as a bridge to transplant candidacy in the era of implantable continuous-flow ventricular assist device. J Artif Organs. 2013; 17(1):16-22. DOI: 10.1007/s10047-013-0731-3. View

Kyo S, Minami T, Nishimura T, Gojo S, Ono M . New era for therapeutic strategy for heart failure: destination therapy by left ventricular assist device. J Cardiol. 2012; 59(2):101-9. DOI: 10.1016/j.jjcc.2012.01.001. View

Schulman A, Martens T, Russo M, Christos P, Gordon R, Lowy F . Effect of left ventricular assist device infection on post-transplant outcomes. J Heart Lung Transplant. 2009; 28(3):237-42. DOI: 10.1016/j.healun.2008.12.007. View

Nishimura T . Current status of extracorporeal ventricular assist devices in Japan. J Artif Organs. 2014; 17(3):211-9. DOI: 10.1007/s10047-014-0779-8. View

Kitamura S . Heart transplantation in Japan: a critical appraisal for the results and future prospects. Gen Thorac Cardiovasc Surg. 2012; 60(10):639-44. DOI: 10.1007/s11748-012-0110-7. View

Rose E, Gelijns A, Moskowitz A, Heitjan D, Stevenson L, Dembitsky W . Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2002; 345(20):1435-43. DOI: 10.1056/NEJMoa012175. View

10.

Simon D, Fischer S, Grossman A, Downer C, Hota B, Heroux A . Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis. 2005; 40(8):1108-15. DOI: 10.1086/428728. View

11.

Holman W, Skinner J, Waites K, Benza R, McGiffin D, Kirklin J . Infection during circulatory support with ventricular assist devices. Ann Thorac Surg. 1999; 68(2):711-6. DOI: 10.1016/s0003-4975(99)00529-9. View

12.

Inafuku H, Senaha S, Morishima Y, Nagano T, Arakaki K, Yamashiro S . Infected thoracoabdominal aortic aneurysms including the major abdominal branches in 4 cases. Ann Thorac Cardiovasc Surg. 2008; 14(3):196-9. View

13.

Yamashiro S, Arakaki R, Kise Y, Inafuku H, Kuniyoshi Y . Potential role of omental wrapping to prevent infection after treatment for infectious thoracic aortic aneurysms. Eur J Cardiothorac Surg. 2012; 43(6):1177-82. DOI: 10.1093/ejcts/ezs600. View

14.

Montero M, Horcajada J, Sorli L, Alvarez-Lerma F, Grau S, Riu M . Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections. Infection. 2009; 37(5):461-5. DOI: 10.1007/s15010-009-8342-x. View